Trial Details
Not recruitingBasic Information
| Clinical ID | c3102 |
|---|---|
| Identifier | NCT02086968 |
| Trial Title | Multicenter Randomized Open-label Controlled Study to Investigate Treatment Response of IV Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia Secondary to Inflammatory Bowel Disease or Gastric Bypass |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Iron Deficiency Anemia Secondary to IBD or Gastric Bypass |
| Interventions | Drug: Injectafer;Drug: Ferrous Sulfate tablets |
Participant Information
| Sponsor | American Regent, Inc. |
|---|---|
| City | - |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | 2020-09-17 |
| Completion Date | - |